MANKIND PHARMA LTD reported a 30% rise in fourth-quarter profit to 5.54 billion rupees ($57.39 million) on Tuesday, up from 4.25 billion rupees a year earlier. The company saw revenue climb 12% to 34.43 billion rupees for the quarter ended March 31. Strong domestic demand for chronic treatments allows Mankind to outperform peers struggling with pricing pressure in the United States.
Mankind Pharma Q4 Profit Rises 30 Percent on Chronic Care
Mankind Pharma reported a 30 percent rise in fourth-quarter profit to 5.54 billion rupees. Growth was led by demand for chronic and consumer health products.
Xurve View
Insights:
Xurve View







